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Cadherins are Ca2F-dependent cell–cell adhesion
molecules, and are involved in the formation and
maintenance of the organocellular architecture. Using
a combination of molecular biologic and biochemical
methods, we analyzed cadherins expressed on cultured
human malignant lymphoma cell lines (adult T cell
lymphomas, human T cell leukemia virus type 1-
negative T cell lines, and thymus-derived lymphoma
cell lines), and obtained evidence that N-cadherin is
the major cadherin expressed on these cells. These
Cadherins are calcium-dependent cell–cell adhesionmolecules that constitute a large superfamily, and areinvolved in the formation and maintenance of thehisto-architecture (Takeichi, 1988). In addition totheir role in normal tissue formation, cadherins seem
to play a crucial role in the cell–cell interaction of cancer cells in
tumorigenesis, invasion, and metastasis (Behrens et al, 1989; Chen
and Obrink, 1991; Navarro et al, 1991; Vleminckx et al, 1991;
Hamaguchi et al, 1993).
The cytoplasmic domain of cadherins interacts with either
β-catenin or γ-catenin (plakoglobin), which in turn binds to
α-catenin, and the resultant complex seems to be associated with
cortical actin filaments (Ozawa et al, 1989; Knudsen and Wheelock,
1992). This interaction between cadherins and catenins is essential
for cadherin-mediated adhesion and association of the complex
with the cytoskeleton (Nagafuchi and Takeichi, 1988; Ozawa et al,
1990; Hirano et al, 1992).
Because cadherins are known to be morphoregulatory molecules
during embryonic development and are important in the mainten-
ance of tissue integrity, there have been a few reports on their
expression and involvement in cells of hematopoietic lineage (Tang
et al, 1993; Lee et al, 1994; Armeanu et al, 1995). We previously
reported that at least two types of cadherins were expressed in certain
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cells were found to form cell aggregates in a Ca2F-
dependent manner, and more importantly to coaggre-
gate and adhere with cells expressing N-cadherin,
suggesting that N-cadherin on lymphoma cells is func-
tionally active. Therefore, N-cadherin expressed on
lymphoma cells could underlie the frequent invasion
of these cells into the mesenchymal tissue in the skin
and the central nervous system. Key words: catenin/
malignant lymphoma/lymphocyte. J Invest Dermatol 112:62–
66, 1999
malignant lymphoma cell lines but not in normal lymphocytes, and
one of them was N-cadherin (Tsutsui et al, 1996). In that study
we could not show that N-cadherin expressed on the cell surface
is functionally active. Furthermore, the nature of the other cadherin
has yet to be determined. To identify other cadherins expressed in
malignant lymphoma cell lines, we used a combination of molecular
biologic and biochemical methods, and obtained evidence that
N-cadherin is the major cadherin expressed on these cells. To
demonstrate that N-cadherin expressed on the cell surface is active,
we changed the conditions for the aggregation assay and found that
cell-expressing N-cadherin forms aggregates in a Ca21-dependent
manner, and more importantly coaggregates with and adheres
with cells expressing N-cadherin, suggesting that N-cadherin on
lymphoma cells is functionally active.
MATERIALS AND METHODS
Cell lines The human transitional carcinoma cell line, BOY (Matsusako
et al, 1992), and human osteosarcoma cell line, HOS (McAllister et al,
1971), were cultured in Dulbecco’s modified Eagle’s medium supplemented
with 10% fetal bovine serum under a 10% CO2 atmosphere at 37°C. The
cloned human T cell leukemia virus type 1-infected cell lines, Oh13T,
F6T, and K3T, have been described previously (Arima et al, 1991). These
cell lines were maintained in RPMI 1640 medium supplemented with
10% fetal calf serum, 0.5 Urecombinant IL-2 (Takeda, Osaka, Japan) per
ml, and 2 µg phytohemagglutinin P (Wako, Osaka, Japan) per ml under a
5% CO2 atmosphere at 37°C. The human T cell leukemia virus type 1-
negative T cell line, Jurkat, and the human thymus-derived T cell line,
Molt-4F, were cultured as described previously (Tsutsui et al, 1996). K562
cells expressing E-cadherin (EK cells) were described previously (Ozawa
and Kemler, 1998). K562 cells expressing N-cadherin (NK cells) were
established by transfecting cells with an expression vector, pCAGGS neo
(Niwa et al, 1991), containing N-cadherin cDNA as described (Ozawa and
Kemler, 1998).
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cDNA cloning cDNA clones were isolated by means of reverse transcrip-
tion-polymerase chain reaction from the cDNA of lymphoma cell lines
(Oh13T and Molt-4F) as described previously (Ozawa et al, 1995). Two
highly conserved amino acid sequences in the cytoplasmic domain were
chosen, and corresponding oligonucleotides, 59 GAATTCACNGCNCC-
NCCNTAYGA (primer 1) and 59 GAATTCTCNGCNARYTTYTTRAA
(primer 2) (Suzuki et al, 1991), were synthesized and used as polymerase
chain reaction primers. The reaction mixture was subjected to 36 cycles
of denaturation (94°C, 1 min), annealing (46°C, 2 min), and extension
(72°C, 3 min). The polymerase chain reaction products (about 130 bp in
size) were isolated and subcloned into the Sma I site of the Bluescript
KS(1) vector (Stratagene). Twenty-three and 68 clones obtained from
Oh13T and Molt-4F cells, respectively, were analyzed by DNA sequencing
using Thermo SequenaseTM1 Cycle sequencing kit (Amersham, Bucks,
U.K.). Homology was searched for using the EMBL database.
Antibodies Antibodies against N-cadherin were purified by affinity
chromatography on Sepharose coupled with the fusion proteins as described
previously (Tsutsui et al, 1996). Antibodies against R-cadherin were a kind
gift of Dr. T. Yanagida (Department of Ophthalmology, Kagoshima
University). The monoclonal antibodies against E- and P-cadherin, and
α- and β-catenin, were obtained from Transduction Laboratories.
Northern blotting Total RNA was prepared from T cell lymphoma
cell lines using ISOGEN (Nippon Gene, Tokyo, Japan). Poly(A)1-RNA
enriched with oligo(dT)-cellulose (Takara, Kusatsu, Japan) was used to
produce cDNA using MMTV reverse transcriptase (Gibco/BRL,
Gaithersburg, MD) and a random-hexamer primer according to the method
described previously (Ozawa et al, 1995). Poly(A)1-RNA (5 µg) was
fractionated by electrophoresis on a 1% agarose gel, and then blotted onto
a nylon membrane (Amersham), and probed with cDNA fragments for
N-, E-, P-, R-, and T1-like cadherin, and cadherin-11, which had been
radiolabeled by the random priming method (Feinberg and Vogelstein,
1983). The hybridization and washing conditions were as described
previously (Ozawa and Muramatsu, 1993).
Western blotting and immunoprecipitation Immunoblotting and
immunoprecipitation were carried out as described previously (Ozawa et al,
1989) except that an ECL kit (Amersham) was used in the immunoblot
experiment. In the immunodepletion experiments, Oh13T cells (1 3 107)
were lyzed with 1 ml of phosphate-buffered saline containing 1% Triton
X-100, 1% Nonidet p-40, 1 mM CaCl2, and 1 mM phenylmethlysulfonyl
fluoride. After centrifugation, a part of the supernatant, trichloroacetic acid
(final 15%), was added to precipitate proteins and used as total cell lysates.
Another part was subjected to immunoprecipitaion using rabbit anti-
N-cadherin antibodies (10 µg) or rabbit anti-human IgG antibodies (10 µg),
as an irrelevant control. After 2 h incubation, the immun-complexes
were collected using protein A-Sepharose. The unabsorbed proteins were
precipitated by the addition of trichloroactetic acid, and used as the
immuno-depleted materials.
Cell aggregation assay and mixing experiments Aggregation assays
were performed as described (Ozawa et al, 1990), with the following
modifications. To obtain single cells, cells were passed through Pasteur
pipettes several times (Ozawa and Kemler, 1998). Thus, trypsin treatment
in the presence of Ca21, a method commonly used to obtain single cells
for a cadherin-mediated aggregation assay (Takeichi, 1988), was not used
in this study. After dissociation, the cells were washed with and suspended
in a 1:1 mixture of HEPES-buffered saline containing 2 mM CaCl2 or
5 mM ethyleneglycol-bis(β-aminoethyl ether)-N,N,N9,N9-tetraacetic acid
and RPMI 1640 containing 5% fetal calf serum. The cells were then
allowed to aggregate for 30 min at 37°C with constant rotation at 30 r.p.m.
The extent of cell aggregation was calculated according to Nagafuchi and
Takeichi (1988) as the index (No – Nt)/No, where Nt is the total particle
number after the incubation (30 min) and No is the total particle number
at the start of the incubation.
Mixing experiments were performed as follows. F6T cells were added
to an equal number of NK or EK cells, which had been labeled with
1,19-dioctadecyl-3,3,39,39-tetramethylindocarbocyanine perchorate (DiI)
(Honig and Hume, 1986). The cells were labeled by adding 2 µl of a
2.5 mg per ml solution of DiI in ethanol per ml of cells. Incubation was
performed for 15 min at 37°C, at which time the cells were collected by
centrifugation and washed extensively with phosphate-buffered saline.
Immunofluorescence microscopic examination revealed that almost all the
cells, if not all, were labeled with the dye. Labeled cells (3 3 105 per ml)
were added to an equal number of F6T cells and then allowed to aggregate
for 30 min at 37°C with constant rotation at 30 r.p.m. The cell aggregates
Figure 1. T cell lymphoma cell lines expressed other cadherins in
addition to N-cadherin. N-cadherin was removed from cell lysates of
Oh13T cells by immunoprecipitation with N-cadherin antibodies as
described under Materials and Methods. Total cell lysates (lanes 1, 4, 7, and
10), the materials collected on immunoprecipitation with N-cadherin
antibodies (lanes 2 and 5) or irrelevant control antibodies (lanes 8 and 11),
and cell lysates depleted with N-cadherin antibodies (lanes 3 and 6) or
control antibodies (lanes 9 and 12), were subjected to immunoblot analysis
with N-cadherin (lanes 1–3, 7–9) or pan-cadherin (lanes 4–6, 10–12)
antibodies. The signal obtained with pan-cadherin antibodies in lane 5 is
stronger than that in lane 6, suggesting that N-cadherin is the major
cadherin in the cells.
were fixed in 3% paraformaldehyde and then examined by phase-contrast
or fluorescence microscopy.
Adhesion to L fibroblasts Molt-4F cells labeled with DiI as described
above were added to L fibroblasts expressing either N-cadherin or
E-cadherin, which had been allowed to spread on cover slips to 50%
confluency, and then incubated for 24 h at 37°C. After gentle washing
three times with phosphate-buffered saline, cells were examined as
described above.
RESULTS AND DISCUSSION
Previously, we found that the N-cadherin-catenin complex is
expressed on certain T cell lymphoma cells (Tsutsui et al, 1996).
To examine the possible expression of cadherins other than
N-cadherin in T cell lymphoma cell lines, we first removed
N-cadherin from Oh13T cell lysates by immunoprecipitation with
N-cadherin antibodies, then the cell lysates were subjected to
immunoblot analysis with pan-cadherin antibodies (Fig 1). As
shown in Fig 1, the lysates depleted of N-cadherin (Fig 1, lane 3)
still contained materials reacting with pan-cadherin antibodies
(Fig 1, lane 6), but not with N-cadherin antibodies (Fig 1, lane
3). Similar results were obtained using Jurkat and Molt-4F cells
(data not shown, but see below). These results demonstrate that in
addition to N-cadherin, another member(s) of the cadherin family
is expressed in T cell lymphoma cell lines. Quantitative analysis
revealed, however, that N-cadherin is the major cadherin expressed
in these cells.
Because the pan-cadherin antibodies were raised against the
conserved carboxy-terminal amino acid residues of N-cadherin, it
is possible that some cadherins are poorly recognized by the
antibodies. Therefore, we next isolated cDNA from the T cell
lymphoma cell lines with the aid of polymerase chain reaction.
This method comprises polymerase chain reaction with degenerate
primers based on well-conserved amino acid sequences of the
intracellular domains of cadherin molecules and sequencing of the
products obtained, and has been successfully used to isolate cDNA
for new cadherins expressed in nervous tissues (Suzuki et al, 1991).
In addition to cDNA for N-cadherin, cDNA encoding R- and
P-cadherins were obtained from Molt-4F cells, and cDNA for
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Figure 2. Northern blot analysis revealed the expression of mRNA
for N-cadherin, R-cadherin, cadherin-11, and T1-like cadherin.
Poly(A)1 RNA (5 µg) from Jurkat cells and Molt-4F cells were run on
an 1% agarose gel and then transferred to a nylon membrane. The
membrane was probed with the respective cDNA labeled with 32P. Single
transcripts of µ4.3–4.8 kb were detected.
Figure 3. N- and R-cadherin, but not cadherin-11, were expressed
in human T cell lymphoma cell lines. Jurkat cells and Molt-4F cells
were subjected to immunoblot analysis with anti-N-cadherin, R-cadherin,
and cadherin-11 antibodies. As positive controls for N-cadherin,
R-cadherin, and cadherin-11, BOY, a human transitional carcinoma cell
line, rat brain, and HOS, a human osteosarcoma cell line, respectively,
were used.
E-cadherin and cadherin-11 were obtained from Oh13T cells (data
not shown). A cDNA encoding an amino acid sequence that
showed similarity (90% identity) to mouse T1-cadherin (Munro
and Blaschuk, 1996; Munro et al, 1996) was also isolated from
Oh13T cells. To determine whether or not mRNA for these
cadherins were really expressed in these cells, northern blot analysis
were performed using the respective cDNA probes. The results
shown in Fig 2 reveal that the mRNA for N-cadherin, R-cadherin,
cadherin-11, and T1-like cadherin were expressed in these cells,
but the mRNA for P-cadherin and E-cadherin (data not shown)
were not.
Immunoblot analysis revealed that a large amount of N-cadherin
and a small amount of R-cadherin, but no cadherin-11 protein,
were expressed in Molt-4F and Jurkat cells (Fig 3). Consistent
with the results of northern blot analysis, no E-cadherin or
P-cadherin protein was detected in any of the cell lines examined
(data not shown). Human T cell leukemia virus type 1-infected T
cell lines (Oh13T and F6T cells) expressed N-cadherin but not
R-cadherin (data not shown).
The results described above demonstrate that the major cadherin
expressed in leukemia cells is N-cadherin. In the previous experi-
ments (Tsutsui et al, 1996), we found that N-cadherin is expressed
on the cell surface and is associated with catenins. With the standard
cell aggregation assay employed, however, we could not detect the
cell adhesive activity of N-cadherin expressed on the leukemia
cells. In the assay, intercellular collisions were generated through
rotational forces. Generally, the number of collisions between cells
in suspension is proportional to the rotational speed imposed upon
the suspension; however, as the speed increases, the shear forces
that disrupt new aggregates also become greater. Thus, it may be
expected that only the effects of surface molecules that mediate
relatively strong adhesive interactions will be detected because of
the relatively high shearing forces (Pizzey et al, 1989). Although
Figure 4. Ca2F-dependent aggregation of lymphoma cells. Cells
were allowed to aggregate for 30 min in the presence of 2 mM CaCl2
(closed bars) or 5 mM ethyleneglycol-bis(β-aminoethyl ether)-N,N,N9,N9-
tetraacetic acid (open bars) as described under Materials and Methods. As
positive controls, BOY cells expressing N-cadherin and K562 cells
transfected with N-cadherin cDNA, and as a negative control, Raji cells,
which are negative for N-cadherin expression, were used.
Figure 5. T cell lymphoma cell lines showed N-cadherin-mediated
aggregation under suspension conditions. F6T cells were added to an
equal number of K562 cells expressing N-cadherin (A, B), or K562 cells
expressing E-cadherin (C, D), that had been labeled with DiI, and then
were allowed to aggregate for 30 min. The cell aggregates were examined
by phase-contrast (A, C) or fluorescence microscopy (B, D). Scale bar: 50 µm.
N-cadherin is the major cadherin expressed on leukemia cells, its
relative amount is small as compared with those expressed on other
types of cells such as fibroblasts. Because the adhesive strength
depends on the amount of cell adhesion molecules (Friedlander
et al, 1989), we changed the conditions for the aggregation assay,
i.e., the rotational force of 70 r.p.m. was changed to one of
30 r.p.m. Under these conditions malignant lymphoma cells formed
cell aggregates in a calcium-dependent manner, i.e., cell aggregates
were formed only in the presence of CaCl2 but not in its absence
(Fig 4). These results demonstrate that these cells exibit calcium-
dependent cell aggregation. The lack of function-inhibiting anti-
bodies to N-cadherin, however, prevented us from demonstrating
that the aggregation of these cells is N-cadherin dependent.
To determine whether N-cadherin expressed on these cells is
functional or not, we performed mixing experiments. F6T cells
were added to an equal number of K562 cells expressing N-cadherin
(NK cells) or E-cadherin (EK cells), both of which had been
labeled with the fluorescent dye, DiI, and then allowed to aggregate.
Almost all NK cells or EK cells were labeled with DiI under the
conditions used, and labeling with the dye had no effect on the
aggregating activity of the cells (data not shown). As shown in
Fig 5, F6T cells were found in aggregates of NK cells but not in
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Figure 6. Molt-4F cells adhere to L
fibroblasts expressing N-cadherin but
not to those expressing E-cadherin.
Molt-4F cells labeled with DiI were
allowed to adhere to L fibroblasts
expressing either N-cadherin (A, B),
E-cadherin (C, D), or untransfected L cells
(E, F) for 24 h as described in Materials and
Methods. The cells adhered to L fibroblasts
were examined by phase-contrast (A, C,
E) or fluorescence microscopy (B, D, F).
Scale bar: 50 µm.
ones of EK cells. Thus, N-cadherin expressed on F6T cells is
functional. Analysis with Oh13T, Molt-4F, and Jurkat cells gave
the same results (data not shown). Furthermore, Molt-4F cells were
found to adhere to L fibroblasts expressing N-cadherin but not to
those expressing E-cadherin (Fig 6).
In this study, we have obtained evidence that although a small
amount of R-cadherin is expressed in some malignant T cell
lymphoma cell lines, N-cadherin is the major cadherin expressed
in lymphoma cells. Cadherins are involved in the formation and
maintenance of the histo-architecture (Takeichi, 1988). In that
sense, our finding that the cadherin–catenin complex is expressed
on T cell lymphoma cell lines is rather unexpected because
lymphocytes do not form a tissue structure. The physiologic
meaning of the expression of the cadherin–catenin complex remains
to be determined. The frequent invasion of lymphoma cells
into the central nervous system has been reported (Jellinger and
Radaszkiewicz, 1976). Therefore, the expression of N-cadherin
could be related to the ability of certain lymphomas to invade or
metastasize. The expression of N-cadherin is not restricted to neural
tissues; instead, N-cadherin is widely expressed in various tissues.
Some squamous cell carcinomas were found to express N-cadherin
in situ and these tumors expressing N-cadherin were invasive (Islam
et al, 1996). The possible involvement of N-cadherin expressed on
breast cancer cells in facilitating invasion and metastasis by promot-
ing their interaction with the surrounding stromal cells was recently
proposed (Hazan et al, 1997).
Finally, if the malignant transformation of lymphocytes induces
the expression of certain cadherins, cadherins could be useful
markers for the diagnosis of and therapy for malignant lymphomas.
Further studies are needed to examine the possible use of cadherins
as markers for identifying certain types of lymphoma cells.
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